Effect of dexmedetomidine as adjunct to penile block for pediatric urologic surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130816014372N11

Enrollment

Registered

2019-06-08

Start date

2019-06-20

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypospadias. Hypospadias

Interventions

Intervention 1: Intervention group 1:Patients in the intervention group one receive dorsal penile nerve blocks via bupivacaine(bupivacaine,Mylan,A.S.A, France)( 0.5%) 0.1 mg / kg. Intervention 2: Int

Eligibility

Sex/Gender

Male

Age

6 Months to 6 Years

Inclusion criteria

Inclusion criteria: 6 months to 6 years male ASA I - II urology surgery (hypospadias)

Exclusion criteria

Exclusion criteria: asthma known or suspected coagulation disorders children with a history of allergy to drugs infection at the injection site history of congenital heart disease history of liver disease delayed growth and mental retardation

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: At the arrival to the recovery room and 1,2,4 h post-operatively. Method of measurement: Modified Observers Assessment of Alertness/ Sedation Scale.;Pain. Timepoint: At the arrival to the recovery room and 1,2,4 h post-operatively. Method of measurement: Numerical rating scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolnaz Gharatti Jahroomi

Shiraz University of Medical Sciences

g.gharaati@gmail.com+98 36474270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026